Aquestive: Rare Opportunity With Dual Platform Strategy

Company Overview - Aquestive Therapeutics (NASDAQ: AQST) is a small-cap pharmaceutical company founded in 2004, specializing in unique film-based medicines for various indications [1] - The company has developed the "PharmFilm" platform, which serves as an alternative to invasive delivery methods [1] Investment Interest - The primary investment interest lies in biotech, with over a decade of investment experience in this sector [1] - Secondary interests include dividend growth equities and business development companies (BDC) [1]